Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Price
Target price
€121.50

€121.50

1.840%
2.2
1.840%
€180.00

€180.00

 
18:27 / Tradegate WKN: 867261 / Symbol: QDEL / Name: Quidel / Stock / Healthcare Equipment & Supplies / Small Cap /
Latest predictions
12.07.21
11.59%
buy
€180.00
28.11.20
-23.26%
buy
06.10.20
-43.89%
buy
28.06.20
-39.92%
buy
Your prediction

Quidel Corp. Stock

There is an upward development for Quidel Corp. compared to yesterday, with an increase of €2.20 (1.840%).
Currently there is a rather positive sentiment for Quidel Corp. with 4 Buy predictions and 0 Sell predictions.
As a result the target price of €180.00 shows a positive potential of 48.148% compared to the current price of €121.50 for Quidel Corp..
For the coming years our community has positive and negative things to say abot the Quidel Corp. stock. Criterium "Innovation" gathered the most positive votes but regarding "General Risks" there were negative voices in the community.

Pros and Cons of Quidel Corp. in the next few years

Pros
1
Innovative
Cons
1
Higher risks for its business

Performance of Quidel Corp. vs. its peers

Security Change(%) 1w 1m 1y YTD 3y 5y
Quidel Corp. 1.840% 2.756% 12.973% -52.280% -19.392% - -
Luna Innovations Inc. 1.940% 3.960% 16.022% 121.519% 36.364% 223.077% 786.824%
Simulations Plus -1.520% 1.563% -16.309% -34.454% -32.759% 144.361% 449.993%
Castlight Healt.b -4.690% -2.139% -12.019% 100.000% 67.890% -33.212% -39.544%

Other discussions about Quidel Corp. Stock

New thread Forum

News

Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation and Transitions BNP Business to Beckman Coulter: https://mms.businesswire.com/media/20191114005606/en/588971/5/Quidel_Horiz_Sml_Vector_CMYK.jpg
Quidel Announces Agreement With Beckman Coulter That Terminates Ongoing Litigation and Transitions BNP Business to Beckman Coulter


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, today announced its entry into

State of Delaware Selects Quidel for COVID-19 Testing Program at Schools: https://mms.businesswire.com/media/20191114005606/en/588971/5/Quidel_Horiz_Sml_Vector_CMYK.jpg
State of Delaware Selects Quidel for COVID-19 Testing Program at Schools


Quidel Corporation (NASDAQ: QDEL) (“Quidel”), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, announced today that it is

Quidel to Hold Fiscal Second Quarter 2021 Financial Results Conference Call on August 5th, 2021: https://mms.businesswire.com/media/20191114005606/en/588971/5/Quidel_Horiz_Sml_Vector_CMYK.jpg
Quidel to Hold Fiscal Second Quarter 2021 Financial Results Conference Call on August 5th, 2021


Quidel Corporation (NASDAQ: QDEL), a leading provider of rapid diagnostic testing solutions, cellular-based virology assays and molecular diagnostic systems, will report fiscal second quarter 2021